Skip to main content

Table 2 The expression difference of VAV1, RHOA, and ZC3HAV1 in transcription level between tumor samples and normal liver tissues from Oncomine database

From: STING pathway contributes to the prognosis of hepatocellular carcinoma and identification of prognostic gene signatures correlated to tumor microenvironment

Genes

Cohorts

Cancer type

Sample counts

Expression type

Fold change

P-value

t-test

Tumor

Liver

VAV1

Mas liver

HCC

38

19

Elevated in tumor

1.21

3.58E-06

4.999

RHOA

Chen Liver

HCC

104

76

Elevated in tumor

1.38

1.05E-10

6.743

Mas Liver

HCC

38

19

Elevated in tumor

1.36

5.78E-05

4.240

Roessler Liver 2

HCC

225

220

Elevated in tumor

1.57

2.85E-24

10.739

ZC3HAV1

Wurmbach Liver

HCC

35

10

Elevated in tumor

2.18

5.34E-09

7.103

Chen Liver

HCC

104

76

Elevated in tumor

1.32

5.13E-09

6.011

Mas Liver

HCC

38

19

Elevated in tumor

1.23

3.47E-09

3.665

Guichard Liver

HCC

99

86

Elevated in tumor

1.05

9.37E-09

5.034

Roessler Liver

HCC

22

21

Elevated in tumor

1.25

1.70E-02

2.218

Roessler Liver 2

HCC

225

220

Elevated in tumor

1.11

6.48E-08

5.371

Guichard Liver 2

HCC

26

26

Elevated in tumor

1.02

4.00E-02

1.824